X0202 SCHEDULE 13G 0000909440 XXXXXXXX LIVE Common Stock, par value $0.001 per share 03/27/2026 0001624326 PAVmed Inc. 70387R502 360 MADISON AVENUE 25TH FLOOR NEW YORK NY 10017 Rule 13d-1(c) NAGELBERG DAVID S X1 546964.00 0.00 546964.00 0.00 546964.00 8.6 IN David S. Nagelberg 2003 Revocable Trust Dtd. 07/02/03 FL 461539.00 0.00 461539.00 0.00 461539.00 7.2 OO Trust PAVmed Inc. 360 MADISON AVENUE, 25TH FLOOR, NEW YORK, NEW YORK, 10017. This Schedule 13G is filed by the David S. Nagelberg 2003 Revocable Trust Dtd. 07/02/03 ("Trust") and David Nagelberg ("Mr. Nagelberg," and together with the Trust, the "Reporting Persons"). Mr. Nagelberg controls the Trust. The Reporting Persons have entered into a Joint Filing Agreement, a copy of which is filed as Exhibit 99.1 to the Schedule 13G, pursuant to which such Reporting Persons have agreed to file the Schedule 13G and all amendments thereto jointly in accordance with the provisions of Rule 13d-1(k) of the Act. Any disclosures herein with respect to persons other than the Reporting Persons are made on information and belief after making inquiry to the appropriate party. The filing of this Schedule 13G should not be construed in and of itself as an admission by any Reporting Person as to beneficial ownership of the shares of Common Stock reported herein. The principal business address of each of the Reporting Persons is c/o Graubard Miller, 405 Lexington Avenue, 44th Floor, New York, New York 10174. The Trust is a trust governed by the laws of Florida. Mr. Nagelberg is a citizen of the United States. Y The Trust beneficially owns 461,539 shares of Common Stock. Mr. Nagelberg may be deemed to beneficially own the shares of Common Stock held by the Trust, because Mr. Nagelberg controls the Trust. Mr. Nagelberg beneficially owns an additional 85,425 shares of Common Stock. The Trust beneficially owns 7.2% of the outstanding shares of Common Stock. Mr. Nagelberg beneficially owns 8.6% of the outstanding shares of Common Stock. The percentage of beneficial ownership is calculated based on 6,383,089 shares of Common Stock outstanding as of March 27, 2026, as set forth in the Company's annual report on Form 10-K filed on March 27, 2026. Trust: 461,539 shares Mr. Nagelberg: 546,964 shares Trust: 0 shares Mr. Nagelberg: 0 shares Trust: 461,539 shares Mr. Nagelberg: 546,964 shares Trust: 0 shares Mr. Nagelberg: 0 shares Y N Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. 99.1 Joint Filing Agreement (filed herewith). NAGELBERG DAVID S /s/ David Nagelberg 04/08/2026 David S. Nagelberg 2003 Revocable Trust Dtd. 07/02/03 /s/ David Nagelberg 04/08/2026